Matinas BioPharma (NYSE:MTNB) Holdings, Inc. (NYSE American:MTNB), a pharmaceutical company specializing in the development ...

BEDMINSTER, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) (the “Company”) today announced that the Company entered into a securities purchase ...

Thank you for your patience and understanding. About Matinas BioPharmaMatinas BioPharma is a biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal ...

Evelyn D’An has been appointed as an independent director and Chair of the Audit Committee, bringing extensive corporate governance and financial oversight experience to Matinas BioPharma's ...

Matinas BioPharma (MTNB) announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as independent members, effective March 11, 2025.

1 Day MTNB -0.73% DJIA 0.85% Russell 2K 1.19% Health Care/Life Sciences -0.59% ...

Short interest in Matinas BioPharma Holdings Inc (AMEX:MTNB) decreased during the last reporting period, falling from 291.99K to 232.41K. This put 4.69% of the company's publicly available shares ...

Matinas BioPharma Holdings, Inc. BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry ...

Detailed price information for Matinas Biopharma Hl (MTNB-A) from The Globe and Mail including charting and trades.